Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1978 4
1979 5
1980 2
1981 3
1983 7
1984 2
1985 10
1986 8
1987 13
1988 30
1989 72
1990 92
1991 93
1992 90
1993 103
1994 102
1995 75
1996 91
1997 99
1998 80
1999 83
2000 94
2001 102
2002 87
2003 114
2004 99
2005 104
2006 102
2007 121
2008 118
2009 160
2010 138
2011 164
2012 166
2013 152
2014 155
2015 178
2016 189
2017 207
2018 196
2019 202
2020 188
2021 224
2022 183
2023 189
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

4,370 results

Results by year

Filters applied: . Clear all
Page 1
International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS, Mullighan CG, Borowitz MJ. Duffield AS, et al. Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24. Virchows Arch. 2023. PMID: 36422706 Free PMC article. Review.
The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute lymphoblastic leukemia (T-ALL) includes both revisions to subtypes previously outlined in the 2016 WHO classification and several newly described entities. …
The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute lymphoblastic l …
Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities.
Burkhardt B, Hermiston ML. Burkhardt B, et al. Br J Haematol. 2019 Jun;185(6):1158-1170. doi: 10.1111/bjh.15793. Epub 2019 Feb 27. Br J Haematol. 2019. PMID: 30809797 Free article. Review.
Lymphoblastic lymphoma (LBL) is the second most common type of Non-Hodgkin Lymphoma (NHL) in childhood and adolescence, accounting for 25-35% of all cases. The majority, 70-80%, is of T-lymphoblastic origin while 20-25% arise from B lymphoblasts. With …
Lymphoblastic lymphoma (LBL) is the second most common type of Non-Hodgkin Lymphoma (NHL) in childhood and adolescence, …
Lymphoblastic Lymphoma: a Concise Review.
Intermesoli T, Weber A, Leoncin M, Frison L, Skert C, Bassan R. Intermesoli T, et al. Curr Oncol Rep. 2022 Jan;24(1):1-12. doi: 10.1007/s11912-021-01168-x. Epub 2022 Jan 20. Curr Oncol Rep. 2022. PMID: 35059993 Review.
PURPOSE OF REVIEW: Lymphoblastic lymphoma (LBL) is a rare, highly aggressive non-Hodgkin lymphoma variant virtually indistinguishable from acute lymphoblastic leukemia (ALL). ...Positron-emission tomography, genetic risk classifications, and minimal di …
PURPOSE OF REVIEW: Lymphoblastic lymphoma (LBL) is a rare, highly aggressive non-Hodgkin lymphoma variant virtually ind …
Acute lymphoblastic leukaemia.
Malard F, Mohty M. Malard F, et al. Lancet. 2020 Apr 4;395(10230):1146-1162. doi: 10.1016/S0140-6736(19)33018-1. Lancet. 2020. PMID: 32247396 Review.
Acute lymphoblastic leukaemia develops in both children and adults, with a peak incidence between 1 year and 4 years. ...However, the outcome of older adults (40 years) and patients with relapsed or refractory acute lymphoblastic leukaemia remains poor. New immunoth …
Acute lymphoblastic leukaemia develops in both children and adults, with a peak incidence between 1 year and 4 years. ...However, the …
Update on Lymphoblastic Leukemia/Lymphoma.
Luca DC. Luca DC. Clin Lab Med. 2021 Sep;41(3):405-416. doi: 10.1016/j.cll.2021.04.003. Clin Lab Med. 2021. PMID: 34304772 Review.
These neoplastic processes can be of B-cell or T-cell derivation and are composed of immature precursors of either lineage. The classification of B-lymphoblastic neoplasms relies predominantly on genetic and molecular findings, whereas the same is not true fo …
These neoplastic processes can be of B-cell or T-cell derivation and are composed of immature precursors of either lineage. Th …
Pediatric acute lymphoblastic leukemia.
Inaba H, Mullighan CG. Inaba H, et al. Haematologica. 2020 Nov 1;105(11):2524-2539. doi: 10.3324/haematol.2020.247031. Haematologica. 2020. PMID: 33054110 Free PMC article. Review.
Although mutation- or pathway-directed targeted therapy (e.g., using tyrosine kinase inhibitors to treat Philadelphia chromosome [Ph]-positive and Phlike B-cell-ALL) is currently available for only a minority of children with ALL, many of the newly identified molecular alt …
Although mutation- or pathway-directed targeted therapy (e.g., using tyrosine kinase inhibitors to treat Philadelphia chromosome [Ph]-positi …
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults.
Temple WC, Mueller S, Hermiston ML, Burkhardt B. Temple WC, et al. Best Pract Res Clin Haematol. 2023 Mar;36(1):101449. doi: 10.1016/j.beha.2023.101449. Epub 2023 Feb 16. Best Pract Res Clin Haematol. 2023. PMID: 36907639 Free article. Review.
Lymphoblastic lymphoma (LBL) is the second most common type of non-Hodgkin Lymphoma (NHL) in children, adolescents, and young adults (CAYA), accounting for 25-35% of all cases. T-lymphoblastic lymphoma (T-LBL) comprises 70-80% of cases, while …
Lymphoblastic lymphoma (LBL) is the second most common type of non-Hodgkin Lymphoma (NHL) in children, adolescents, and …
Biology of childhood acute lymphoblastic leukemia.
Bhojwani D, Yang JJ, Pui CH. Bhojwani D, et al. Pediatr Clin North Am. 2015 Feb;62(1):47-60. doi: 10.1016/j.pcl.2014.09.004. Pediatr Clin North Am. 2015. PMID: 25435111 Free PMC article. Review.
Giant strides have been made in the management of childhood acute lymphoblastic leukemia (ALL) over previous decades. Extensive collaborative efforts internationally have played a vital role in the remarkable progress made in not only improving therapeutic outcomes but als …
Giant strides have been made in the management of childhood acute lymphoblastic leukemia (ALL) over previous decades. Extensive colla …
BCR-ABL1-like B-Acute Lymphoblastic Leukemia/Lymphoma: A Comprehensive Review.
Jain S, Abraham A. Jain S, et al. Arch Pathol Lab Med. 2020 Feb;144(2):150-155. doi: 10.5858/arpa.2019-0194-RA. Epub 2019 Oct 23. Arch Pathol Lab Med. 2020. PMID: 31644323 Free article. Review.
.-: In the 2016 update of the World Health Organization (WHO) classification of hematopoietic neoplasms, BCR-ABL1-like B-acute lymphoblastic leukemia/lymphoma (B-ALL) is added as a new provisional entity that lacks the BCR-ABL1 translocation but shows a patte …
.-: In the 2016 update of the World Health Organization (WHO) classification of hematopoietic neoplasms, BCR-ABL1-like B-acute lymphoblas …
Adult Acute Lymphoblastic Leukemia: Treatment and Management Updates.
Gregory S. Gregory S. Semin Oncol Nurs. 2019 Dec;35(6):150951. doi: 10.1016/j.soncn.2019.150951. Epub 2019 Nov 20. Semin Oncol Nurs. 2019. PMID: 31759820 Review.
OBJECTIVE: To present an overview of novel therapies for the treatment of adult acute lymphoblastic leukemia and to discuss nursing implications for these new therapies. ...CONCLUSION: Several promising therapies have emerged in the treatment of relapsed/refractory and min …
OBJECTIVE: To present an overview of novel therapies for the treatment of adult acute lymphoblastic leukemia and to discuss nursing i …
4,370 results